Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Jia-Qian Zhang
Circulating Regulatory T Cells Were Absolutely Decreased in Dermatomyositis/Polymyositis Patients and Restored by Low-Dose IL-2
Annals of the Rheumatic Diseases
Immunology
Molecular Biology
Biochemistry
Rheumatology
Allergy
Genetics
Related publications
On the Therapeutic Scope of Low-Dose IL-2. Response To: ‘Circulating Regulatory T Cells Were Absolutelydecreased in Dermatomyositis/Polymyositispatients and Restored by Low-Dose IL-2’ by Zhang Et Al
Annals of the Rheumatic Diseases
Immunology
Molecular Biology
Biochemistry
Rheumatology
Allergy
Genetics
IL-2 Consumption by Highly Activated CD8 T Cells Induces Regulatory T-Cell Dysfunction in Patients With Hemophagocytic Lymphohistiocytosis
Journal of Allergy and Clinical Immunology
Allergy
Immunology
Respiratory Disorders in Patients With Polymyositis/Dermatomyositis
Modern Rheumatology Journal
SAT0252 the Number of Treg Cells in Peripheral Blood in PSS Patients Is Decreased and Low Dose IL-2 Can Promote Its Proliferation
Ultra-Low Dose IL-2 Expands Natural Regulatory T Cells and CD56bright NK Cells in Patients and Healthy Donors and Is Associated With Clinical Improvement in Chronic Graft Versus Host Disease
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Alterations in Circulating Follicular Helper T Cells (cTFH) and Follicular Regulatory T Cells (cTFR) in CVID Patients
Journal of Allergy and Clinical Immunology
Allergy
Immunology
P134/O32 Selective Expansion of a Thymic-Derived and Functionally Competent Regulatory T Cell Population by Low-Dose IL-2 Therapy in Patients With Refractory SLE
Construction of Self-Recognizing Regulatory T Cells From Conventional T Cells by Controlling CTLA-4 and IL-2 Expression
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
THU0412 Absolute Reduction of Peripheral Cd4 + Regulatory T Cell Subset of Patients With Systemic Sclerosis and Its Restoration by Short-Term and Low Dose Il-2 Treatment
